Literature DB >> 22797187

Development of a model of early-onset IgA nephropathy.

Keiko Okazaki1, Yusuke Suzuki, Mareki Otsuji, Hitoshi Suzuki, Masao Kihara, Tadahiro Kajiyama, Azusa Hashimoto, Hiroyuki Nishimura, Rhubell Brown, Stacy Hall, Jan Novak, Shozo Izui, Sachiko Hirose, Yasuhiko Tomino.   

Abstract

ddY mice spontaneously develop IgA nephropathy (IgAN) with a variable age of disease onset. Establishing a model with early-onset IgAN could aid the investigation of mechanisms that underlie the pathogenesis of this disease. On the basis of histologic grading in serial biopsies, we previously classified ddY mice into early-onset, late-onset, and quiescent groups. Here, we selectively mated mice with the early-onset phenotype for >20 generations and established "grouped ddY" mice that develop IgAN within 8 weeks of age. Similar to human IgAN, the prognosis was worse for male mice than females. These mice homogeneously retained genotypes of four marker loci previously associated with the early-onset phenotype, confirming a close association of these loci with early-onset IgAN in ddY mice. Grouped ddY mice comprised two sublines, however, which had distinct genotypes at a susceptibility locus for high serum IgA levels, which maps within the Ig heavy-chain gene complex. The subline bearing the Igh-2(a) IgA allotype had a more rapid course of fatal disease and lower oligosaccharide content, suggesting that aberrant IgA glycosylation may promote the progression of murine IgAN. Taken together, these data indicate that grouped ddY mice may be a useful model for the identification of susceptibility genes and the underlying molecular mechanisms involved in the pathogenesis of human IgAN.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22797187      PMCID: PMC3402288          DOI: 10.1681/ASN.2011121160

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  51 in total

1.  Association between single-nucleotide polymorphisms in selectin genes and immunoglobulin A nephropathy.

Authors:  Takashi Takei; Aritoshi Iida; Kosaku Nitta; Toshihiro Tanaka; Yozo Ohnishi; Ryo Yamada; Shiro Maeda; Tatsuhiko Tsunoda; Sachiyo Takeoka; Kyoko Ito; Kazuho Honda; Keiko Uchida; Ken Tsuchiya; Yasushi Suzuki; Tomoaki Fujioka; Takashi Ujiie; Yutaka Nagane; Satoru Miyano; Ichiei Narita; Fumitake Gejyo; Hiroshi Nihei; Yusuke Nakamura
Journal:  Am J Hum Genet       Date:  2002-02-01       Impact factor: 11.025

2.  ACE gene polymorphism and IgA nephropathy: an ethnically homogeneous study and a meta-analysis.

Authors:  F P Schena; C D'Altri; G Cerullo; C Manno; L Gesualdo
Journal:  Kidney Int       Date:  2001-08       Impact factor: 10.612

3.  Polymorphism of the uteroglobin gene in systemic lupus erythematosus and IgA nephropathy.

Authors:  Elisa Menegatti; Antonella Nardacchione; Mirella Alpa; Cecilia Agnes; Daniela Rossi; Marica Chiara; Vittorio Modena; Luigi M Sena; Dario Roccatello
Journal:  Lab Invest       Date:  2002-05       Impact factor: 5.662

Review 4.  Enigmas in the pathogenesis of IgA nephropathy.

Authors:  L A van Es; A W van den Wall Bake; R K Stad; M E van den Dobbelsteen; M J Bogers; M R Daha
Journal:  Contrib Nephrol       Date:  1995       Impact factor: 1.580

5.  Single-nucleotide polymorphisms in the class II region of the major histocompatibility complex in Japanese patients with immunoglobulin A nephropathy.

Authors:  Fumihiro Akiyama; Toshihiro Tanaka; Ryo Yamada; Yozo Ohnishi; Tatsuhiko Tsunoda; Shiro Maeda; Takashi Takei; Wataru Obara; Kyoko Ito; Kazuho Honda; Keiko Uchida; Ken Tsuchiya; Kosaku Nitta; Wako Yumura; Hiroshi Nihei; Takashi Ujiie; Yutaka Nagane; Satoru Miyano; Yasushi Suzuki; Tomoaki Fujioka; Ichiei Narita; Fumitake Gejyo; Yusuke Nakamura
Journal:  J Hum Genet       Date:  2002       Impact factor: 3.172

6.  Mouse IgA allotypes have major differences in their hinge regions.

Authors:  Julia M Phillips-Quagliata
Journal:  Immunogenetics       Date:  2002-02-20       Impact factor: 2.846

7.  IgA nephropathy, the most common cause of glomerulonephritis, is linked to 6q22-23.

Authors:  A G Gharavi; Y Yan; F Scolari; F P Schena; G M Frasca; G M Ghiggeri; K Cooper; A Amoroso; B F Viola; G Battini; G Caridi; C Canova; A Farhi; V Subramanian; C Nelson-Williams; S Woodford; B A Julian; R J Wyatt; R P Lifton
Journal:  Nat Genet       Date:  2000-11       Impact factor: 38.330

8.  Role of uteroglobin G38A polymorphism in the progression of IgA nephropathy in Japanese patients.

Authors:  Ichiei Narita; Noriko Saito; Shin Goto; Song Jin; Kentaro Omori; Minoru Sakatsume; Fumitake Gejyo
Journal:  Kidney Int       Date:  2002-05       Impact factor: 10.612

9.  Interaction between ACE and ADD1 gene polymorphisms in the progression of IgA nephropathy in Japanese patients.

Authors:  Ichiei Narita; Shin Goto; Noriko Saito; Jin Song; Junya Ajiro; Fuminori Sato; Daisuke Saga; Daisuke Kondo; Kohei Akazawa; Minoru Sakatsume; Fumitake Gejyo
Journal:  Hypertension       Date:  2003-07-28       Impact factor: 10.190

10.  Association of single-nucleotide polymorphisms in the polymeric immunoglobulin receptor gene with immunoglobulin A nephropathy (IgAN) in Japanese patients.

Authors:  Wataru Obara; Aritoshi Iida; Yasushi Suzuki; Toshihiro Tanaka; Fumihiro Akiyama; Shiro Maeda; Yozo Ohnishi; Ryo Yamada; Tatsuhiko Tsunoda; Takashi Takei; Kyoko Ito; Kazuho Honda; Keiko Uchida; Ken Tsuchiya; Wako Yumura; Takashi Ujiie; Yutaka Nagane; Kosaku Nitta; Satoru Miyano; Ichiei Narita; Fumitake Gejyo; Hiroshi Nihei; Tomoaki Fujioka; Yusuke Nakamura
Journal:  J Hum Genet       Date:  2003-05-10       Impact factor: 3.172

View more
  19 in total

1.  Development of Animal Models of Human IgA Nephropathy.

Authors:  Hitoshi Suzuki; Yusuke Suzuki; Jan Novak; Yasuhiko Tomino
Journal:  Drug Discov Today Dis Models       Date:  2014

2.  Determination of severity of murine IgA nephropathy by glomerular complement activation by aberrantly glycosylated IgA and immune complexes.

Authors:  Azusa Hashimoto; Yusuke Suzuki; Hitoshi Suzuki; Isao Ohsawa; Rhubell Brown; Stacy Hall; Yuichi Tanaka; Jan Novak; Hiroyuki Ohi; Yasuhiko Tomino
Journal:  Am J Pathol       Date:  2012-08-05       Impact factor: 4.307

Review 3.  New insights into the pathogenesis of IgA nephropathy.

Authors:  Jürgen Floege; Ivan C Moura; Mohamed R Daha
Journal:  Semin Immunopathol       Date:  2014-01-18       Impact factor: 9.623

4.  Follicular dendritic cell secreted protein FDC-SP controls IgA production.

Authors:  S Hou; I Landego; N Jayachandran; A Miller; I W Gibson; C Ambrose; A J Marshall
Journal:  Mucosal Immunol       Date:  2014-01-08       Impact factor: 7.313

5.  Crucial Role of AIM/CD5L in the Development of Glomerular Inflammation in IgA Nephropathy.

Authors:  Akiko Takahata; Satoko Arai; Emiri Hiramoto; Kento Kitada; Rina Kato; Yuko Makita; Hitoshi Suzuki; Junichiro Nakata; Kimi Araki; Toru Miyazaki; Yusuke Suzuki
Journal:  J Am Soc Nephrol       Date:  2020-07-01       Impact factor: 10.121

Review 6.  Autoimmune-mediated renal disease and hypertension.

Authors:  Erika I Boesen; Rahul M Kakalij
Journal:  Clin Sci (Lond)       Date:  2021-09-17       Impact factor: 6.876

7.  O-linked glycosylation determines the nephritogenic potential of IgA rheumatoid factor.

Authors:  Masao Kihara; Kiyoaki Ito; Junichiro Nakata; Masako Otani; Ngoc Lan Tran; Naoki Morito; Satoru Takahashi; Yoshinao Wada; Shozo Izui
Journal:  J Am Soc Nephrol       Date:  2014-02-07       Impact factor: 10.121

Review 8.  Optimizing the translational value of animal models of glomerulonephritis: insights from recent murine prototypes.

Authors:  Mary H Foster
Journal:  Am J Physiol Renal Physiol       Date:  2016-06-22

9.  TLR9 activation induces aberrant IgA glycosylation via APRIL- and IL-6-mediated pathways in IgA nephropathy.

Authors:  Yuko Makita; Hitoshi Suzuki; Toshiki Kano; Akiko Takahata; Bruce A Julian; Jan Novak; Yusuke Suzuki
Journal:  Kidney Int       Date:  2019-09-05       Impact factor: 10.612

Review 10.  Are there animal models of IgA nephropathy?

Authors:  Renato C Monteiro; Yusuke Suzuki
Journal:  Semin Immunopathol       Date:  2021-07-07       Impact factor: 9.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.